Yahoo Finance • 11 days ago

Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?

Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped ease investor conc... Full story

Yahoo Finance • 11 days ago

Danaher Beat Earnings Estimates, so Why Are Investors Still Concerned About Growth?

Danaher Corporation (NYSE:DHR) delivered second-quarter results on July 21, marked by core growth improving compared to the previous quarter, along with disciplined execution that drove high-single-digit adjusted EPS growth. Despite beatin... Full story

Yahoo Finance • 12 days ago

Agilent Technologies (A) Expands Its Oncology Diagnostics Reach—Can Growth Keep Up?

Agilent Technologies Inc. (NYSE:A) just extended its diagnostics franchise into one of oncology's toughest corners. On July 23, the company said European regulators had certified its PD-L1 IHC 22C3 pharmDx test, Code SK006, as a companion... Full story

Yahoo Finance • 15 days ago

Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts' average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, sur... Full story

Yahoo Finance • 20 days ago

Notable healthcare headlines for the week: Eli Lilly, Molina Healthcare, and Roche in focus

Wall Street's major averages aimed to go higher on Friday but closed mixed as oil prices declined. The benchmark S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_... Full story

Yahoo Finance • 22 days ago

Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity

Shareholders in biotechnology, life sciences, and diagnostics solutions company Danaher (NYSE: DHR) have had an interesting week. Their stock crashed early in the week on the release of its second-quarter earnings, only to recover somewhat... Full story

Yahoo Finance • 23 days ago

Cell Culture Market Analysis by Consumables, Vessels, Equipment, Application, and Competition - Global Forecast to 2031

Company Logo Biopharmaceutical production led applications in 2025, while sera, media and reagents dominated consumables. Asia-Pacific is expected to record the fastest growth through 2031. Key players include Thermo Fisher Scientific, Da... Full story

Yahoo Finance • 24 days ago

Apple Fails to Overturn $634 Million Masimo Verdict

This article first appeared on GuruFocus. Apple (AAPL, Financials), the consumer technology company behind the iPhone and Apple Watch, failed to overturn a $634 million jury verdict in a patent dispute with medical technology company Masi... Full story

Yahoo Finance • 24 days ago

Apple Stumbles in Court as $634 Million Apple Watch Judgment Survives

This article first appeared on GuruFocus. Apple (NASDAQ:AAPL) has lost its attempt to set aside a $634 million jury award tied to a patent dispute with Masimo over blood oxygen monitoring technology used in Apple Watch devices. A Califor... Full story

Yahoo Finance • 24 days ago

Don’t Quit on Danaher Stock After Horrific Earnings Reaction

To say Danaher Corp. had a downbeat reaction to earnings is an understatement. Danaher had its worst day in two decades on Tuesday after the life sciences and diagnostics company’s second-quarter earnings. Danaher expects core revenue... Full story

Yahoo Finance • 24 days ago

US Stock Market Today S&P 500 Futures Rise On Earnings And Inflation Crosscurrents

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. The Morning Bull - US Market Morning Update Wednesday, Jul, 22 2026 US stock futures are pointing higher, with key contracts link... Full story

Yahoo Finance • 25 days ago

Stock Indexes Settle Higher as Chipmakers Soar

The S&P 500 Index ($SPX) (SPY) on Tuesday closed up +0.89%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.74%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.93%.  September E-mini S&P futures (ESU26) rose +0.81%, and Se... Full story

Yahoo Finance • 25 days ago

Update: Equity Markets Rise Intraday in Tech-Led Advance

(Updates with latest market prices and developments.) US benchmark equity indexes were higher int PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n... Full story

Yahoo Finance • 25 days ago

Strength in Chipmakers Boosts Stocks

The S&P 500 Index ($SPX) (SPY) today is up +0.64%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.47%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.58%.  September E-mini S&P futures (ESU26) are up +0.62%, and September E-mini... Full story

Yahoo Finance • 25 days ago

Danaher forecasts 3%-4% 2026 core revenue growth and raises adjusted EPS to $8.45-$8.60 following Masimo close

Earnings Call Insights: Danaher (DHR) Q2 2026 MANAGEMENT VIEW * "We delivered a solid second quarter with better-than-expected revenue, earnings and cash flow" (President, CEO & Director Rainer Blair), adding, "Our Life Sciences busine... Full story

Yahoo Finance • 25 days ago

Stocks Gain as Chipmakers Rebound

The S&P 500 Index ($SPX) (SPY) today is up +0.38%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.17%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.26%.  September E-mini S&P futures (ESU26) are up +0.35%, and September E-mini... Full story

Yahoo Finance • 25 days ago

Danaher Q2 Earnings Call Highlights

Key Points Interested in Danaher Corporation? Here are five stocks we like better. Danaher beat Q2 expectations with sales of $6.3 billion, adjusted EPS of $1.94, and $1.3 billion in free cash flow. Core revenue rose 3% year over year, wi... Full story

Yahoo Finance • 25 days ago

Oppenheimer Picks Apple, Amazon, Alphabet as Top Stock Buys

This article first appeared on GuruFocus. Oppenheimer said investors may want to use the recent pullback in higher-beta stocks to selectively add equity exposure rather than adopt a defensive stance. The firm said recent market action re... Full story

Yahoo Finance • 25 days ago

Stocks Rise Pre-Bell as Investors Await More Earnings, Monitor Middle East Developments

US equity futures were tracking in the green on Tuesday as traders await the latest batch of corpora PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 25 days ago

Tech Rebound Boosts Wall Street Pre-Bell; Asia, Europe Up

Wall Street futures pointed higher pre-bell Tuesday as tech traders toggled risk-on switches despite PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story